Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians: The Strong Heart Family Study

N. Franceschini, K. Haack, H. H H Göring, V. S. Voruganti, S. Laston, L. Almasy, E. T. Lee, L. G. Best, R. R. Fabsitz, K. E. North, J. W. MacCluer, J. B. Meigs, J. S. Pankow, S. A. Cole

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims/hypothesis: Type 2 diabetes is a chronic, heterogeneous disease and a major risk factor for cardiovascular diseases. The underlying mechanisms leading to progression to type 2 diabetes are not fully understood and genetic tools may help to identify important pathways of glycaemic deterioration. Methods: Using prospective data on American Indians from the Strong Heart Family Study, we identified 373 individuals defined as progressors (diabetes incident cases), 566 individuals with transitory impaired fasting glucose (IFG) and 1,011 controls (normal fasting glycaemia at all visits). We estimated the heritability (h2) of the traits and the evidence for association with 16 known variants identified in type 2 diabetes genome-wide association studies. Results: We noted high h2 for diabetes progression (h2 = 0.65 ± 0.16, p = 2.7 × 10-6) but little contribution of genetic factors to transitory IFG (h2 = 0.09 ± 0.10, p = 0.19) for models adjusted for multiple risk factors. At least three variants (in WFS1, TSPAN8 and THADA) were nominally associated with diabetes progression in age- and sex-adjusted analyses with estimates showing the same direction of effects as reported in the discovery European ancestry studies. Conclusions/interpretation: Our findings do not exclude these loci for diabetes susceptibility in American Indians and suggest phenotypic heterogeneity of the IFG trait, which may have implications for genetic studies when diagnosis is based on a single time-point measure.

Original languageEnglish (US)
Pages (from-to)2194-2202
Number of pages9
JournalDiabetologia
Volume56
Issue number10
DOIs
StatePublished - Oct 2013
Externally publishedYes

Fingerprint

Molecular Epidemiology
North American Indians
Fasting
Type 2 Diabetes Mellitus
Glucose
Genome-Wide Association Study
Chronic Disease
Cardiovascular Diseases

Keywords

  • Heritability
  • Impaired fasting glucose
  • Single nucleotide polymorphisms
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Franceschini, N., Haack, K., Göring, H. H. H., Voruganti, V. S., Laston, S., Almasy, L., ... Cole, S. A. (2013). Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians: The Strong Heart Family Study. Diabetologia, 56(10), 2194-2202. https://doi.org/10.1007/s00125-013-2988-8

Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians : The Strong Heart Family Study. / Franceschini, N.; Haack, K.; Göring, H. H H; Voruganti, V. S.; Laston, S.; Almasy, L.; Lee, E. T.; Best, L. G.; Fabsitz, R. R.; North, K. E.; MacCluer, J. W.; Meigs, J. B.; Pankow, J. S.; Cole, S. A.

In: Diabetologia, Vol. 56, No. 10, 10.2013, p. 2194-2202.

Research output: Contribution to journalArticle

Franceschini, N, Haack, K, Göring, HHH, Voruganti, VS, Laston, S, Almasy, L, Lee, ET, Best, LG, Fabsitz, RR, North, KE, MacCluer, JW, Meigs, JB, Pankow, JS & Cole, SA 2013, 'Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians: The Strong Heart Family Study', Diabetologia, vol. 56, no. 10, pp. 2194-2202. https://doi.org/10.1007/s00125-013-2988-8
Franceschini, N. ; Haack, K. ; Göring, H. H H ; Voruganti, V. S. ; Laston, S. ; Almasy, L. ; Lee, E. T. ; Best, L. G. ; Fabsitz, R. R. ; North, K. E. ; MacCluer, J. W. ; Meigs, J. B. ; Pankow, J. S. ; Cole, S. A. / Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians : The Strong Heart Family Study. In: Diabetologia. 2013 ; Vol. 56, No. 10. pp. 2194-2202.
@article{254a4a59a803426593a1615546357214,
title = "Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians: The Strong Heart Family Study",
abstract = "Aims/hypothesis: Type 2 diabetes is a chronic, heterogeneous disease and a major risk factor for cardiovascular diseases. The underlying mechanisms leading to progression to type 2 diabetes are not fully understood and genetic tools may help to identify important pathways of glycaemic deterioration. Methods: Using prospective data on American Indians from the Strong Heart Family Study, we identified 373 individuals defined as progressors (diabetes incident cases), 566 individuals with transitory impaired fasting glucose (IFG) and 1,011 controls (normal fasting glycaemia at all visits). We estimated the heritability (h2) of the traits and the evidence for association with 16 known variants identified in type 2 diabetes genome-wide association studies. Results: We noted high h2 for diabetes progression (h2 = 0.65 ± 0.16, p = 2.7 × 10-6) but little contribution of genetic factors to transitory IFG (h2 = 0.09 ± 0.10, p = 0.19) for models adjusted for multiple risk factors. At least three variants (in WFS1, TSPAN8 and THADA) were nominally associated with diabetes progression in age- and sex-adjusted analyses with estimates showing the same direction of effects as reported in the discovery European ancestry studies. Conclusions/interpretation: Our findings do not exclude these loci for diabetes susceptibility in American Indians and suggest phenotypic heterogeneity of the IFG trait, which may have implications for genetic studies when diagnosis is based on a single time-point measure.",
keywords = "Heritability, Impaired fasting glucose, Single nucleotide polymorphisms, Type 2 diabetes",
author = "N. Franceschini and K. Haack and G{\"o}ring, {H. H H} and Voruganti, {V. S.} and S. Laston and L. Almasy and Lee, {E. T.} and Best, {L. G.} and Fabsitz, {R. R.} and North, {K. E.} and MacCluer, {J. W.} and Meigs, {J. B.} and Pankow, {J. S.} and Cole, {S. A.}",
year = "2013",
month = "10",
doi = "10.1007/s00125-013-2988-8",
language = "English (US)",
volume = "56",
pages = "2194--2202",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians

T2 - The Strong Heart Family Study

AU - Franceschini, N.

AU - Haack, K.

AU - Göring, H. H H

AU - Voruganti, V. S.

AU - Laston, S.

AU - Almasy, L.

AU - Lee, E. T.

AU - Best, L. G.

AU - Fabsitz, R. R.

AU - North, K. E.

AU - MacCluer, J. W.

AU - Meigs, J. B.

AU - Pankow, J. S.

AU - Cole, S. A.

PY - 2013/10

Y1 - 2013/10

N2 - Aims/hypothesis: Type 2 diabetes is a chronic, heterogeneous disease and a major risk factor for cardiovascular diseases. The underlying mechanisms leading to progression to type 2 diabetes are not fully understood and genetic tools may help to identify important pathways of glycaemic deterioration. Methods: Using prospective data on American Indians from the Strong Heart Family Study, we identified 373 individuals defined as progressors (diabetes incident cases), 566 individuals with transitory impaired fasting glucose (IFG) and 1,011 controls (normal fasting glycaemia at all visits). We estimated the heritability (h2) of the traits and the evidence for association with 16 known variants identified in type 2 diabetes genome-wide association studies. Results: We noted high h2 for diabetes progression (h2 = 0.65 ± 0.16, p = 2.7 × 10-6) but little contribution of genetic factors to transitory IFG (h2 = 0.09 ± 0.10, p = 0.19) for models adjusted for multiple risk factors. At least three variants (in WFS1, TSPAN8 and THADA) were nominally associated with diabetes progression in age- and sex-adjusted analyses with estimates showing the same direction of effects as reported in the discovery European ancestry studies. Conclusions/interpretation: Our findings do not exclude these loci for diabetes susceptibility in American Indians and suggest phenotypic heterogeneity of the IFG trait, which may have implications for genetic studies when diagnosis is based on a single time-point measure.

AB - Aims/hypothesis: Type 2 diabetes is a chronic, heterogeneous disease and a major risk factor for cardiovascular diseases. The underlying mechanisms leading to progression to type 2 diabetes are not fully understood and genetic tools may help to identify important pathways of glycaemic deterioration. Methods: Using prospective data on American Indians from the Strong Heart Family Study, we identified 373 individuals defined as progressors (diabetes incident cases), 566 individuals with transitory impaired fasting glucose (IFG) and 1,011 controls (normal fasting glycaemia at all visits). We estimated the heritability (h2) of the traits and the evidence for association with 16 known variants identified in type 2 diabetes genome-wide association studies. Results: We noted high h2 for diabetes progression (h2 = 0.65 ± 0.16, p = 2.7 × 10-6) but little contribution of genetic factors to transitory IFG (h2 = 0.09 ± 0.10, p = 0.19) for models adjusted for multiple risk factors. At least three variants (in WFS1, TSPAN8 and THADA) were nominally associated with diabetes progression in age- and sex-adjusted analyses with estimates showing the same direction of effects as reported in the discovery European ancestry studies. Conclusions/interpretation: Our findings do not exclude these loci for diabetes susceptibility in American Indians and suggest phenotypic heterogeneity of the IFG trait, which may have implications for genetic studies when diagnosis is based on a single time-point measure.

KW - Heritability

KW - Impaired fasting glucose

KW - Single nucleotide polymorphisms

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84890115816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890115816&partnerID=8YFLogxK

U2 - 10.1007/s00125-013-2988-8

DO - 10.1007/s00125-013-2988-8

M3 - Article

C2 - 23851660

AN - SCOPUS:84890115816

VL - 56

SP - 2194

EP - 2202

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -